National Cultures and International Competition: The Experience of Schering AG, 18511950: The Experience of Schering AG, 1851-1950 (Cambridge Studies in the Emergence of Global Enterprise)
In case you failed to run a Google search this week, you may not have realized that on Tuesday Nov. 10, Sesame Street turns 40 . You gotta admit, the show doesn't look a day over five--and that's without Botox. If you've forgotten how to get to Sesame Street , we have a few reminders--and ear worms -- appropriately tailored for the biopharma industry--hey, it's our version of personalized medicine...
To Schering we bid our fondest adieu; Founder Ernst might weep at the shame. Your German sibling has shuffled off, too, But Bayer, at least, saved his name. Source
A day after drugmaker Merck & Co. completed its $41.1 billion purchase of rival Schering-Plough Corp., Fitch Ratings Service on Wednesday cut its ratings on Merck and upgraded Schering-Plough.
NEW YORK -- A day after drugmaker Merck & Co. completed its $41.1 billion purchase of rival Schering-Plough Corp., Fitch Ratings Service on Wednesday cut its ratings on Merck and upgraded Schering-Plough.
Merck & Co. Inc. completed its planned $41 billion acquisition of Schering-Plough Corp. yesterday after the stock markets closed. The deal creates the world's second-largest drugmaker, behind Pfizer Inc. Patent expirations on top-selling drugs such as Merck's asthma drug Singulair helped drive the combination.
After 28 weeks of treatment, Schering-Plough said 25 percent of the null responders had a "sustained virologic response," meaning their virus levels were too low to measure. After 48 weeks of treatment, 55 percent of patients had a sustained virologic response.
Schering-Plough Healthcare Products, Inc. v. Schwarz Pharma, Inc., -- F.3d --, 2009 WL 3460808 (7th Cir.) As entertaining as a Posner opinion always is, I fear this one has more than enough casual language in it to do mischief to the law; it will likely be much cited, whether for heat or for light. Discussion of opinion below , dismissing Schering’s false advertising claims. Schering sells an...
In August 2009, asenapine (Saphris; Schering–Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults.
SAN FRANCISCO (MarketWatch) -- Priceline.com [s:pcln] will replace Schering-Plough Corp. in the S&P 500 on an undisclosed date, Standard & Poor's said late Thursday. The change stems from Schering-Plough's pending merger with S&P 500 constituent Merck & Co. , the index publisher said. Also, Freeport-McMoRan Copper & Gold Inc. , already a member of the S&P 500, will replace...
Merck received US anti trust approval of its merger with Schering Plough. They are waiting on Chinese approval, which is a mere formality. The deal will likely close next week. I expect the health care sector to get a boost as it did when the Pfizer/Wyeth deal closed. The boost will likely be smaller as the cash component of this deal is smaller.
BrooklynDodger(s) comment: These novel assay experiments should be related to exposure levels in which toxicity or carcinogenicity is expressed in an intact animal. Toxicology and Applied Pharmacology Volume 241, Issue 2 , 1 December 2009, Pages 230-245 Toxicogenomic analysis of N -nitrosomorpholine induced changes in rat liver: Comparison of genomic and proteomic responses and anchoring to histopathological...
Bayer Schering Pharma’s World Contraception Day kicks off with online press conference Working in conjunction with Kreative Konzeption and Ketchum, CScout helped organize the online press conference for the annual World Contraception Day which took place on September 24, 2009. The media event featured members of the Youth Task Force (YTF), a group of young regional [...]